10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0000049071-22-000032 |
| Period End Date | 20220331 |
| Filing Date | 20220427 |
| Fiscal Year | 2022 |
| Fiscal Period | Q1 |
| XBRL Instance | hum-20220331_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
78 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Receivables, allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$83.00M | USD | Point-in-time |
| Receivables, allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$69.00M | USD | Point-in-time |
| Preferred stock, par (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$1.00 | USD | Point-in-time |
| Preferred stock, par (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$1.00 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$3.39B | USD | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$4.86B | USD | Point-in-time |
| Preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Investment securities |
ShortTermInvestments
|
$13.19B | USD | Point-in-time |
| Investment securities |
ShortTermInvestments
|
$13.09B | USD | Point-in-time |
| Preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Common stock, par (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.17 | USD | Point-in-time |
| Common stock, par (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.17 | USD | Point-in-time |
| Receivables, less allowance for doubtful accounts of $69 in 2022 and $83 in 2021 |
ReceivablesNetCurrent
|
$1.81B | USD | Point-in-time |
| Receivables, less allowance for doubtful accounts of $69 in 2022 and $83 in 2021 |
ReceivablesNetCurrent
|
$3.17B | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
300.00M | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
300.00M | shares | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$6.49B | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$5.71B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$26.84B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$24.89B | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
198.65M | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
198.65M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$3.07B | USD | Point-in-time |
| Treasury stock, shares (in shares) |
TreasuryStockShares
|
69.85M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$3.19B | USD | Point-in-time |
| Treasury stock, shares (in shares) |
TreasuryStockShares
|
72.16M | shares | Point-in-time |
| Long-term investment securities |
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
$780.00M | USD | Point-in-time |
| Long-term investment securities |
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
$392.00M | USD | Point-in-time |
| Equity method investments |
EquityMethodInvestments
|
$141.00M | USD | Point-in-time |
| Equity method investments |
EquityMethodInvestments
|
$138.00M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$11.09B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$11.14B | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$4.38B | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$4.61B | USD | Point-in-time |
| Total assets |
Assets
|
$46.31B | USD | Point-in-time |
| Total assets |
Assets
|
$44.36B | USD | Point-in-time |
| Benefits payable |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$8.29B | USD | Point-in-time |
| Benefits payable |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$9.38B | USD | Point-in-time |
| Benefits payable |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$8.65B | USD | Point-in-time |
| Benefits payable |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$8.14B | USD | Point-in-time |
| Trade accounts payable and accrued expenses |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$4.51B | USD | Point-in-time |
| Trade accounts payable and accrued expenses |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$5.86B | USD | Point-in-time |
| Book overdraft |
BookOverdraftLiability
|
$326.00M | USD | Point-in-time |
| Book overdraft |
BookOverdraftLiability
|
$317.00M | USD | Point-in-time |
| Unearned revenues |
ContractWithCustomerLiabilityCurrent
|
$288.00M | USD | Point-in-time |
| Unearned revenues |
ContractWithCustomerLiabilityCurrent
|
$254.00M | USD | Point-in-time |
| Short-term debt |
DebtCurrent
|
$1.95B | USD | Point-in-time |
| Short-term debt |
DebtCurrent
|
$1.69B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$15.33B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$17.53B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$10.54B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$11.29B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$2.15B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$2.38B | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$28.25B | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$30.97B | USD | Point-in-time |
| Preferred stock, $1 par; 10,000,000 shares authorized; none issued |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $1 par; 10,000,000 shares authorized; none issued |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,648,742 shares issued at March 31, 2022 and December 31, 2021 |
CommonStockValue
|
$33.00M | USD | Point-in-time |
| Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,648,742 shares issued at March 31, 2022 and December 31, 2021 |
CommonStockValue
|
$33.00M | USD | Point-in-time |
| Capital in excess of par value |
AdditionalPaidInCapitalCommonStock
|
$3.10B | USD | Point-in-time |
| Capital in excess of par value |
AdditionalPaidInCapitalCommonStock
|
$3.08B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$23.91B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$23.09B | USD | Point-in-time |
| Accumulated other comprehensive (loss) income |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-572.00M | USD | Point-in-time |
| Accumulated other comprehensive (loss) income |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$42.00M | USD | Point-in-time |
| Treasury stock, at cost, 72,155,340 shares at March 31, 2022 and 69,846,758 shares at December 31, 2021 |
TreasuryStockValue
|
$10.16B | USD | Point-in-time |
| Treasury stock, at cost, 72,155,340 shares at March 31, 2022 and 69,846,758 shares at December 31, 2021 |
TreasuryStockValue
|
$11.16B | USD | Point-in-time |
| Noncontrolling interests |
MinorityInterest
|
$23.00M | USD | Point-in-time |
| Noncontrolling interests |
MinorityInterest
|
$23.00M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$13.73B | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.19B | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.10B | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.34B | USD | Point-in-time |
| Total liabilities and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$46.31B | USD | Point-in-time |
| Total liabilities and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$44.36B | USD | Point-in-time |
Income Statement
38 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Premiums |
PremiumsEarnedNet
|
$20.12B | USD | 1 Quarter |
| Premiums |
PremiumsEarnedNet
|
$22.70B | USD | 1 Quarter |
| Services |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$466.00M | USD | 1 Quarter |
| Services |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$1.26B | USD | 1 Quarter |
| Investment income |
NetInvestmentIncome
|
$3.00M | USD | 1 Quarter |
| Investment income |
NetInvestmentIncome
|
$78.00M | USD | 1 Quarter |
| Total revenues |
Revenues
|
$23.97B | USD | 1 Quarter |
| Total revenues |
Revenues
|
$20.67B | USD | 1 Quarter |
| Benefits |
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
$17.30B | USD | 1 Quarter |
| Benefits |
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
$19.62B | USD | 1 Quarter |
| Operating costs |
SellingGeneralAndAdministrativeExpense
|
$2.89B | USD | 1 Quarter |
| Operating costs |
SellingGeneralAndAdministrativeExpense
|
$2.01B | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationAndAmortizationIncomeStatement
|
$142.00M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationAndAmortizationIncomeStatement
|
$170.00M | USD | 1 Quarter |
| Total operating expenses |
BenefitsLossesAndExpenses
|
$22.68B | USD | 1 Quarter |
| Total operating expenses |
BenefitsLossesAndExpenses
|
$19.45B | USD | 1 Quarter |
| Income from operations |
OperatingIncomeLoss
|
$1.29B | USD | 1 Quarter |
| Income from operations |
OperatingIncomeLoss
|
$1.22B | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$68.00M | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$90.00M | USD | 1 Quarter |
| Other (income) expense, net |
OtherNonoperatingIncomeExpense
|
$-115.00M | USD | 1 Quarter |
| Other (income) expense, net |
OtherNonoperatingIncomeExpense
|
$21.00M | USD | 1 Quarter |
| Income before income taxes and equity in net earnings |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$1.04B | USD | 1 Quarter |
| Income before income taxes and equity in net earnings |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$1.22B | USD | 1 Quarter |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$233.00M | USD | 1 Quarter |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$286.00M | USD | 1 Quarter |
| Equity in net (losses) earnings |
IncomeLossFromEquityMethodInvestments
|
$21.00M | USD | 1 Quarter |
| Equity in net (losses) earnings |
IncomeLossFromEquityMethodInvestments
|
$-4.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$828.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$930.00M | USD | 1 Quarter |
| Less: Net income attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Less: Net income attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Net income attributable to Humana |
NetIncomeLoss
|
$930.00M | USD | 1 Quarter |
| Net income attributable to Humana |
NetIncomeLoss
|
$828.00M | USD | 1 Quarter |
| Basic earnings per common share (in dollars per share) |
EarningsPerShareBasic
|
$6.42 | USD | 1 Quarter |
| Basic earnings per common share (in dollars per share) |
EarningsPerShareBasic
|
$7.32 | USD | 1 Quarter |
| Diluted earnings per common share (in dollars per share) |
EarningsPerShareDiluted
|
$6.39 | USD | 1 Quarter |
| Diluted earnings per common share (in dollars per share) |
EarningsPerShareDiluted
|
$7.29 | USD | 1 Quarter |
Cash Flow Statement
76 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income attributable to Humana |
ProfitLoss
|
$930.00M | USD | 1 Quarter |
| Net income attributable to Humana |
ProfitLoss
|
$828.00M | USD | 1 Quarter |
| Losses (gains) on investment securities, net |
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
$-76.00M | USD | 1 Quarter |
| Losses (gains) on investment securities, net |
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
$10.00M | USD | 1 Quarter |
| Equity in net losses (earnings) |
IncomeLossFromEquityMethodInvestments
|
$21.00M | USD | 1 Quarter |
| Equity in net losses (earnings) |
IncomeLossFromEquityMethodInvestments
|
$-4.00M | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$39.00M | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$43.00M | USD | 1 Quarter |
| Depreciation |
Depreciation
|
$153.00M | USD | 1 Quarter |
| Depreciation |
Depreciation
|
$181.00M | USD | 1 Quarter |
| Amortization |
AdjustmentForAmortization
|
$15.00M | USD | 1 Quarter |
| Amortization |
AdjustmentForAmortization
|
$24.00M | USD | 1 Quarter |
| Receivables |
IncreaseDecreaseInReceivables
|
$1.36B | USD | 1 Quarter |
| Receivables |
IncreaseDecreaseInReceivables
|
$1.05B | USD | 1 Quarter |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$628.00M | USD | 1 Quarter |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$1.09B | USD | 1 Quarter |
| Benefits payable |
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
$466.00M | USD | 1 Quarter |
| Benefits payable |
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
$1.09B | USD | 1 Quarter |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$-103.00M | USD | 1 Quarter |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$-151.00M | USD | 1 Quarter |
| Unearned revenues |
IncreaseDecreaseInContractWithCustomerLiability
|
$34.00M | USD | 1 Quarter |
| Unearned revenues |
IncreaseDecreaseInContractWithCustomerLiability
|
$7.00M | USD | 1 Quarter |
| Other |
OtherOperatingActivitiesCashFlowStatement
|
$-19.00M | USD | 1 Quarter |
| Other |
OtherOperatingActivitiesCashFlowStatement
|
$12.00M | USD | 1 Quarter |
| Net cash provided by (used in) operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$302.00M | USD | 1 Quarter |
| Net cash provided by (used in) operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-837.00M | USD | 1 Quarter |
| Acquisitions, net of cash and cash equivalents acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$74.00M | USD | 1 Quarter |
| Acquisitions, net of cash and cash equivalents acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$123.00M | USD | 1 Quarter |
| Purchases of property and equipment, net |
PaymentsToAcquirePropertyPlantAndEquipment
|
$290.00M | USD | 1 Quarter |
| Purchases of property and equipment, net |
PaymentsToAcquirePropertyPlantAndEquipment
|
$295.00M | USD | 1 Quarter |
| Purchases of investment securities |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$2.16B | USD | 1 Quarter |
| Purchases of investment securities |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$3.72B | USD | 1 Quarter |
| Proceeds from maturities of investment securities |
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
$588.00M | USD | 1 Quarter |
| Proceeds from maturities of investment securities |
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
$692.00M | USD | 1 Quarter |
| Proceeds from sales of investment securities |
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
$1.29B | USD | 1 Quarter |
| Proceeds from sales of investment securities |
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
$1.95B | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-648.00M | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-1.49B | USD | 1 Quarter |
| Receipts from contract deposits, net |
PaymentsForProceedsFromContractDeposits
|
$-1.01B | USD | 1 Quarter |
| Receipts from contract deposits, net |
PaymentsForProceedsFromContractDeposits
|
$-2.48B | USD | 1 Quarter |
| Proceeds from issuance of senior notes, net |
ProceedsFromIssuanceOfSeniorLongTermDebt
|
$744.00M | USD | 1 Quarter |
| Proceeds from issuance of senior notes, net |
ProceedsFromIssuanceOfSeniorLongTermDebt
|
- | USD | 1 Quarter |
| (Repayments) proceeds from issuance of commercial paper, net |
ProceedsFromRepaymentsOfCommercialPaper
|
$-265.00M | USD | 1 Quarter |
| (Repayments) proceeds from issuance of commercial paper, net |
ProceedsFromRepaymentsOfCommercialPaper
|
$603.00M | USD | 1 Quarter |
| Debt issue costs |
PaymentsOfDebtIssuanceCosts
|
- | USD | 1 Quarter |
| Debt issue costs |
PaymentsOfDebtIssuanceCosts
|
$1.00M | USD | 1 Quarter |
| Change in book overdraft |
IncreaseDecreaseInBookOverdrafts
|
$-9.00M | USD | 1 Quarter |
| Change in book overdraft |
IncreaseDecreaseInBookOverdrafts
|
$23.00M | USD | 1 Quarter |
| Common stock repurchases |
PaymentsForRepurchaseOfCommonStock
|
$30.00M | USD | 1 Quarter |
| Common stock repurchases |
PaymentsForRepurchaseOfCommonStock
|
$1.02B | USD | 1 Quarter |
| Dividends paid |
PaymentsOfDividends
|
$83.00M | USD | 1 Quarter |
| Dividends paid |
PaymentsOfDividends
|
$91.00M | USD | 1 Quarter |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-13.00M | USD | 1 Quarter |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$1.00M | USD | 1 Quarter |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$1.53B | USD | 1 Quarter |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$1.82B | USD | 1 Quarter |
| Increase (decrease) in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-796.00M | USD | 1 Quarter |
| Increase (decrease) in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$1.47B | USD | 1 Quarter |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.88B | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.39B | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.86B | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.67B | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.88B | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.39B | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.86B | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.67B | USD | Point-in-time |
| Interest payments |
InterestPaidNet
|
$40.00M | USD | 1 Quarter |
| Interest payments |
InterestPaidNet
|
$67.00M | USD | 1 Quarter |
| Income tax payments, net |
IncomeTaxesPaidNet
|
$-20.00M | USD | 1 Quarter |
| Income tax payments, net |
IncomeTaxesPaidNet
|
$-1.00M | USD | 1 Quarter |
| Fair value of assets acquired, net of cash and cash equivalents acquired |
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
|
$264.00M | USD | 1 Quarter |
| Fair value of assets acquired, net of cash and cash equivalents acquired |
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
|
$84.00M | USD | 1 Quarter |
| Less: Fair value of liabilities assumed |
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
$141.00M | USD | 1 Quarter |
| Less: Fair value of liabilities assumed |
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
$10.00M | USD | 1 Quarter |
| Cash paid for acquired businesses, net of cash and cash equivalents acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$123.00M | USD | 1 Quarter |
| Cash paid for acquired businesses, net of cash and cash equivalents acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$74.00M | USD | 1 Quarter |
Stockholders Equity
22 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$13.73B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.19B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.10B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.34B | USD | Point-in-time |
| Net income attributable to Humana |
ProfitLoss
|
$930.00M | USD | 1 Quarter |
| Net income attributable to Humana |
ProfitLoss
|
$828.00M | USD | 1 Quarter |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTax
|
$-283.00M | USD | 1 Quarter |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTax
|
$-614.00M | USD | 1 Quarter |
| Common stock repurchases |
TreasuryStockValueAcquiredCostMethod
|
$30.00M | USD | 1 Quarter |
| Common stock repurchases |
TreasuryStockValueAcquiredCostMethod
|
$1.02B | USD | 1 Quarter |
| Dividends and dividend equivalents |
DividendsCommonStockCash
|
$101.00M | USD | 1 Quarter |
| Dividends and dividend equivalents |
DividendsCommonStockCash
|
$93.00M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$39.00M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$43.00M | USD | 1 Quarter |
| Restricted stock unit vesting |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 1 Quarter |
| Restricted stock unit vesting |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 1 Quarter |
| Stock option exercises |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$1.00M | USD | 1 Quarter |
| Stock option exercises |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$5.00M | USD | 1 Quarter |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$13.73B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.19B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.10B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.34B | USD | Point-in-time |
Comprehensive Income
20 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income attributable to Humana |
ProfitLoss
|
$930.00M | USD | 1 Quarter |
| Net income attributable to Humana |
ProfitLoss
|
$828.00M | USD | 1 Quarter |
| Change in gross unrealized investment (losses) gains |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$-769.00M | USD | 1 Quarter |
| Change in gross unrealized investment (losses) gains |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$-320.00M | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
$-73.00M | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
$-176.00M | USD | 1 Quarter |
| Total change in unrealized investment (losses) gains, net of tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-247.00M | USD | 1 Quarter |
| Total change in unrealized investment (losses) gains, net of tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-593.00M | USD | 1 Quarter |
| Reclassification adjustment for net realized gains |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
$55.00M | USD | 1 Quarter |
| Reclassification adjustment for net realized gains |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
$27.00M | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
|
$6.00M | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
|
$13.00M | USD | 1 Quarter |
| Total reclassification adjustment, net of tax |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$42.00M | USD | 1 Quarter |
| Total reclassification adjustment, net of tax |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$21.00M | USD | 1 Quarter |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-614.00M | USD | 1 Quarter |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-289.00M | USD | 1 Quarter |
| Comprehensive (loss) income attributable to equity method investments |
ComprehensiveIncomeLossNetOfTaxAttributableToEquityMethodInvestments
|
- | USD | 1 Quarter |
| Comprehensive (loss) income attributable to equity method investments |
ComprehensiveIncomeLossNetOfTaxAttributableToEquityMethodInvestments
|
$6.00M | USD | 1 Quarter |
| Comprehensive income attributable to Humana |
ComprehensiveIncomeNetOfTax
|
$316.00M | USD | 1 Quarter |
| Comprehensive income attributable to Humana |
ComprehensiveIncomeNetOfTax
|
$545.00M | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.